Type to search

Novavax Announces Expanded Agreement with SK bioscience to Manufacture COVID-19 Vaccine Containing Omicron Variant and Manufacture the Novavax COVID-19 Vaccine in Prefilled Syringes | Pharmtech Focus
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over | Pharmtech Focus
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine | Pharmtech Focus